TEST:

Merlin Assay

NCCN Melanoma 2023 updates: Basically no change regarding prognostic gene expression profile (GEP) tests. DecisionDx Melanoma, Merlin test, etc still not recommended. $CSTL @skylinedx ()

@skylinedx Announces #Medicare #Coverage for Its Predictive Melanoma Assay Merlin Test @Exponential_nl https://t.co/EEK4aIMVAZ #newsmedia #informationtechnology #martech #news #digitaladvertising #marketingtechnology #readmagazine ()

New collaborative paper online on how Merlin Test reduces unnecessary surgeries and associated complications 👇 https://t.co/yCYGTYHZBH #melanoma #diagnostics #MerlinTest ()

CP-GEP (Merlin Assay, SkyLineDx) combines Breslow thickness and patient age with the expression levels of eight genes from the primary melanoma. Stratification is based on their risk for nodal metastasis: CP-GEP Low Risk or CP-GEP High Risk. (@OlofssonBagge)